MEDINICE SPÓŁKA AKCYJNA financials
MEDINICE SPÓŁKA AKCYJNA
Country: PL Reporting currency: PLN Latest annual report: 2022-12-31
LEI:
259400LGO9UDV1Y18Z11 Financial statements
(PLN, as reported — unscaled; 110 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 246.0K | PLN 285.0K |
| Employee benefits expense | PLN 2.9M | PLN 1.8M |
| Raw materials & consumables used | PLN 111.0K | PLN 74.0K |
| Depreciation & amortisation | PLN 314.0K | PLN 362.0K |
| Operating profit (EBIT) | -PLN 5.0M | -PLN 3.3M |
| Finance costs | PLN 75.0K | PLN 59.0K |
| Profit before tax | -PLN 4.9M | -PLN 2.9M |
| Income tax expense | PLN 0 | PLN 10.0K |
| Profit for the year | -PLN 4.9M | -PLN 2.9M |
| — attributable to owners | -PLN 4.9M | -PLN 2.9M |
| — attributable to NCI | PLN 0 | PLN 3.0K |
| Total comprehensive income | -PLN 4.9M | -PLN 2.9M |
| Per share | ||
| Basic EPS | PLN -0.79 | PLN -0.50 |
| Diluted EPS | PLN -0.77 | PLN -0.48 |
| Free cash flow / share | PLN -0.51 | PLN -0.34 |
| Cash flow statement | ||
| Net cash from operating activities | -PLN 2.8M | -PLN 1.7M |
| Net cash from investing activities | -PLN 4.1M | -PLN 6.6M |
| Purchase of PP&E (capex) | PLN 448.0K | PLN 314.0K |
| Purchase of intangibles | PLN 3.1M | PLN 4.0M |
| Net cash from financing activities | -PLN 3.9M | PLN 28.7M |
| Proceeds from borrowings | PLN 0 | PLN 0 |
| Repayments of borrowings | PLN 350.0K | PLN 0 |
| Lease liability payments | PLN 82.0K | PLN 78.0K |
| Net change in cash | -PLN 10.8M | PLN 20.4M |
| Balance sheet | ||
| Total assets | PLN 41.9M | PLN 49.1M |
| Non-current assets | PLN 20.0M | PLN 16.3M |
| Property, plant & equipment | PLN 831.0K | PLN 532.0K |
| Intangible assets & goodwill | PLN 0 | PLN 0 |
| Current assets | PLN 21.9M | PLN 32.9M |
| Trade & other receivables | PLN 741.0K | PLN 918.0K |
| Cash & equivalents | PLN 21.2M | PLN 31.9M |
| Total equity | PLN 37.1M | PLN 40.5M |
| — attributable to owners | PLN 37.1M | PLN 40.5M |
| Non-controlling interests | PLN 0 | PLN 0 |
| Non-current liabilities | PLN 3.8M | PLN 7.4M |
| Lease liabilities (non-current) | PLN 288.0K | PLN 272.0K |
| Current liabilities | PLN 1.0M | PLN 1.2M |
| Trade & other payables | PLN 625.0K | PLN 379.0K |
| Deferred tax liabilities | PLN 3.0K | PLN 8.0K |
| Derived metrics | ||
| Free cash flow | -PLN 3.2M | -PLN 2.0M |
| Operating margin | -2032.1% | -1152.6% |
| Net margin | -2002.0% | -1012.6% |
| Return on equity | -13.3% | -7.1% |
| Cash conversion ratio | 0.57× | 0.59× |
| Capex coverage | -6.22× | -5.43× |
| Other reported items | ||
| Adjustments For Decrease Increase In Other Assets | PLN 14.0K | -PLN 813.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -PLN 413.0K | -PLN 865.0K |
| Adjustments For Deferred Tax Expense | PLN 0 | PLN 0 |
| Adjustments For Depreciation and Amortisation Expense | PLN 314.0K | PLN 362.0K |
| Adjustments For Finance Costs | PLN 0 | PLN 0 |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | PLN 0 | PLN 0 |
| Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities | PLN 328.0K | PLN 65.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | -PLN 236.0K | PLN 115.0K |
| Adjustments For Interest Income | PLN 22.0K | PLN 36.0K |
| Adjustments For Provisions | PLN 1.0K | -PLN 61.0K |
| Adjustments For Sharebased Payments | PLN 1.5M | PLN 798.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -PLN 20.0K | -PLN 24.0K |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | PLN 1.8M | PLN 424.0K |
| Basic Earnings Loss Per Share From Continuing Operations | PLN -0.79 | PLN -0.50 |
| Basic Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | PLN 600.0K | PLN 0 |
| Cash Advances and Loans Made To Related Parties | PLN 0 | PLN 0 |
| Changes In Equity | -PLN 3.4M | PLN 23.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | PLN 0 | PLN 3.0K |
| Comprehensive Income Attributable To Owners of Parent | -PLN 4.9M | -PLN 2.9M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | PLN 206.0K | PLN 388.0K |
| Current Provisions | PLN 94.0K | PLN 90.0K |
| Deferred Tax Assets | PLN 3.0K | PLN 7.0K |
| Diluted Earnings Loss Per Share From Continuing Operations | PLN -0.77 | PLN -0.48 |
| Diluted Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | PLN 0 | PLN 0 |
| Equity and Liabilities | PLN 41.9M | PLN 49.1M |
| Expense By Nature | PLN 5.2M | PLN 3.6M |
| Finance Income | PLN 415.0K | PLN 903.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | PLN 266.0K | PLN 435.0K |
| Increase Decrease In Cash and Cash Equivalents | -PLN 10.8M | PLN 20.4M |
| Increase Decrease In Working Capital | PLN 320.0K | PLN 746.0K |
| Increase Decrease Through Sharebased Payment Transactions | PLN 1.5M | PLN 3.0M |
| Intangible Assets Other Than Goodwill | PLN 13.5M | PLN 10.5M |
| Interest Paid Classified As Financing Activities | PLN 17.0K | PLN 33.0K |
| Investments In Subsidiaries Joint Ventures and Associates | PLN 5.6M | PLN 5.2M |
| Issue of Equity | PLN 8.0K | PLN 24.9M |
| Issued Capital | PLN 627.0K | PLN 619.0K |
| Liabilities | PLN 4.8M | PLN 8.6M |
| Noncurrent Government Grants | PLN 3.5M | PLN 7.2M |
| Noncurrent Portion of Noncurrent Loans Received | PLN 0 | PLN 0 |
| Other Adjustments To Reconcile Profit Loss | -PLN 1.0K | PLN 137.0K |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | PLN 0 | PLN 838.0K |
| Other Cash Receipts From Sales of Interests In Joint Ventures Classified As Investing Activities | PLN 0 | PLN 690.0K |
| Other Comprehensive Income | PLN 0 | PLN 0 |
| Other Current Financial Assets | PLN 0 | PLN 0 |
| Other Current Financial Liabilities | PLN 88.0K | PLN 304.0K |
| Other Current Nonfinancial Assets | PLN 14.0K | PLN 5.0K |
| Other Expense By Nature | PLN 258.0K | PLN 101.0K |
| Other Operating Income Expense | -PLN 362.0K | PLN 215.0K |
| Payments For Share Issue Costs | PLN 0 | PLN 1.4M |
| Proceeds From Government Grants Classified As Financing Activities | PLN 765.0K | PLN 6.2M |
| Proceeds From Issuing Shares | PLN 8.0K | PLN 25.8M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | PLN 0 | PLN 786.0K |
| Profit Loss From Continuing Operations | -PLN 4.9M | -PLN 2.9M |
| Profit Loss From Discontinued Operations | PLN 0 | PLN 0 |
| Purchase of Financial Instruments Classified As Investing Activities | PLN 0 | PLN 2.9M |
| Reserve of Sharebased Payments | PLN 5.1M | PLN 3.6M |
| Restricted Cash and Cash Equivalents | PLN 480.0K | PLN 6.1M |
| Retained Earnings | -PLN 16.1M | -PLN 11.1M |
| Services Expense | PLN 1.3M | PLN 1.4M |
| Share Issue Related Cost | PLN 0 | PLN 1.4M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | PLN 0 | PLN 0 |
| Share Premium | PLN 47.4M | PLN 47.4M |
| Tax Expense Other Than Income Tax Expense | PLN 30.0K | PLN 68.0K |
Methodology
Every line item above is a fact tagged in MEDINICE SPÓŁKA AKCYJNA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.